Fundraising FoxPositron Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
CimCurecimcure.cominJun 2022✓ verified
CimCure develops active cancer vaccines that use its proprietary Immune-Boost (iBoost) technology to prompt the body to produce antibodies that attack and destroy the blood vessels feeding solid tumours, stopping cancer growth.
BiotechHealthtechMedical DevicesAmsterdam, NL
Arjan Griffioen(CSO)inDiederik Engbersen(CEO)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.